SavedAdd your journal

Journals / Çocuk Dergisi / 2006 / Cilt: 6 - Sayı: 2

Diagnosis and treatment of growth hormone deficiency in childhood and adolescence: Consensus guidelines from the national pediatric endocrinology association in Turkey (Part 2) treatment of growth hormone deficiency

Çocukluk ve ergenlik döneminde büyüme hormonu eksikliği tanı ve tedavisi uzlaşı raporu (Bölüm 2) büyüme hormonu eksikliği tedavisi

Feyza DARENDELİLER
Şükran DARCAN
Pages
89–94
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This summary statement from the National Pediatric Endocrinology Association aims to provide guidelines for the use of GH in childhood and adolescence based on the evidence from the literature and experience of the treating physicians in Turkey.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Growth hormone (GH) treatment results in normalization of final height in growth hormone deficiency of childhood.
📊
Key Findings & Data:There are various aspects of growth hormone treatment that have to be taken into consideration in order to optimize final height of the children with growth hormone deficiency on GH treatment.
💡
Conclusion & Impact:This summary statement from the National Pediatric Endocrinology Association aims to provide guidelines for the use of GH in childhood and adolescence based on the evidence from the literature and experience of the treating physicians in Turkey.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Büyüme hormonu · Türkiye · Eksiklik hastalıkları

Abstract

Growth hormone (GH) treatment results in normalization of final height in growth hormone deficiency of childhood. There are various aspects of growth hormone treatment that have to be taken into consideration in order to optimize final height of the children with growth hormone deficiency on GH treatment. This summary statement from the National Pediatric Endocrinology Association aims to provide guidelines for the use of GH in childhood and adolescence based on the evidence from the literature and experience of the treating physicians in Turkey.

Özet

Büyüme hormonu eksikliğinde büyüme hormonu (BH) tedavisi ile nihai boyun normal sınırlar içine geldiği çeşitli çalışmalarda gösterilmiştir. Ancak, büyüme hormonu tedavisinin etkin olabilmesi için çeşitli faktörlerin (BH dozu, başlama yaşı, verilme sıklığı gibi) göz önüne alınması ve değerlendirilmesi gerekmektedir. Bu yazıda çocukluk ve adolesan döneminde büyüme hormonu eksikliğinin tedavisi ile ilgili olarak kanıtlara ve uzmanların görüşlerine dayanarak Türkiye’deki Ulusal Pediyatrik Endokrinoloji Derneği’nin önerileri sunulmuştur.

🔖

Cite This Article

DARENDELİLER, F., DARCAN, Ş. (2006). Diagnosis and treatment of growth hormone deficiency in childhood and adolescence: Consensus guidelines from the national pediatric endocrinology association in Turkey (Part 2) treatment of growth hormone deficiency. Çocuk Dergisi, Cilt: 6 - Sayı: 2, 89–94. https://ajindex.com/articles/213498

References (12)

  1. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Guidelines for the use of growth hormone in children with short stature: A report by the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. J Pediatr 1995; 127: 857-67
  2. Saggese G, Ranke MB, Saenger P, et al. Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Horm Res 1998; 50:320-40
  3. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary Statement of the GH Research Society. J Clin Endocrinol Metab 2000; 85:3990-3
  4. Consensus: Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the growth hormone research society. J Clin Endocrinol Metab 2001; 86:1868-70
  5. Tanaka T, Cohen P, Clayton PE, Laron Z, Hintz RL, Sizonenko PC. Diagnosis and management of growth hormone deficiency in childhood and adolescence -Part 2: Growth hormone treatment in growth hormone deficient children. Growth hormone & IGF Research 2002; 12:323-41
  6. Wilson TA, Rose SR, Cohen P, et al. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 2003: 415-21
  7. Strother DR, Pollack IF, Fisher PG, et al. Tumors of the central nervous system. In: Principles and practice of pediatric oncology. Pizzo PA, Poplock DB (eds) Philadelphia: Lippincott 2002: 751-824
  8. Swerdlow AJ, Reddingius REHHA, Spoudeas HA, et al. Growth hormone treatment of children with brain tumors and risk of tumor recurrence. J Clin Endocrinol Metab 2000; 85:4444-9
  9. Sklar CA, Mertens AC, Mitby P, et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: A report from the childhood cancer survivor study. J Clin Endocrinol Metab 2002; 87:3136-41
  10. Cohen P, Bright MG, Rogol AD, Kappelgaard AM, Rosenfeld RG. On Behalf of The American Norditropin Clinical Trials Group. Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: Implications for efficacy and safety. J Clin Endocrinol Metab 2002; 87:90-8
  11. Tanaka T. Global situation of growth hormone treatment in growth hormone deficient children. Horm Res 1999; 51:75-80
  12. Blethen SL, Baptista J, Kuntze J, Foley T, La Franchi S, Johanson A. Adult height in growth hormone-deficie